GRHPR
| Symbol | GNAS |
|---|---|
| HGNC ID | 4392 |
| Alternative symbols | – |
| Entrez Gene | 2778 |
| OMIM | 139320 |
| RefSeq | NM_080425 |
| UniProt | P63092 |
| Chromosome | 20q13.3 |
| Locus supplementary data | – |
GNAS1 is a complex imprinted gene located on chromosome 20q13.3 that encodes the stimulatory G-protein alpha subunit (Gsα), which is involved in the regulation of adenylate cyclase and the production of cyclic AMP (cAMP) from ATP. This gene plays a crucial role in various signaling pathways and is associated with several genetic disorders.
Structure[edit]
The GNAS1 gene is known for its complex structure, which includes multiple promoters and alternative splicing, leading to the production of different protein isoforms. The gene is subject to genomic imprinting, meaning that the expression of its alleles is parent-of-origin specific. The Gsα protein is encoded by the GNAS1 gene and is a key component of the G-protein coupled receptor (GPCR) signaling pathway.
Function[edit]
The primary function of the Gsα protein is to activate adenylate cyclase, which catalyzes the conversion of ATP to cAMP. cAMP acts as a second messenger in various biological processes, including the regulation of metabolism, cell growth, and hormone secretion. Gsα is involved in the signaling pathways of several hormones, such as parathyroid hormone, thyroid-stimulating hormone, and glucagon.
Clinical Significance[edit]
Mutations in the GNAS1 gene can lead to a variety of disorders, including:
- McCune-Albright syndrome: A condition characterized by fibrous dysplasia of bone, café-au-lait skin spots, and endocrine abnormalities. It is caused by postzygotic mutations in the GNAS1 gene, leading to constitutive activation of the Gsα protein.
- Pseudohypoparathyroidism: A disorder where the body is resistant to parathyroid hormone, leading to low calcium and high phosphate levels in the blood. It is associated with mutations in the GNAS1 gene that affect the Gsα protein function.
- Progressive osseous heteroplasia: A rare disorder characterized by the formation of bone in soft tissues, also linked to mutations in the GNAS1 gene.
Research and Developments[edit]
Ongoing research is focused on understanding the full spectrum of GNAS1-related disorders and the development of targeted therapies. The study of GNAS1 also provides insights into the mechanisms of genomic imprinting and its implications in human disease.
Also see[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
